JOHNSON & JOHNSON DOES DIY TO SOLVE VACCINE WOES / THE FINANCIAL TIMES OP EDITORIAL

Johnson & Johnson does DIY to solve vaccine woes Drugmaker joins growing group using vertical integration to address bottlenecks and res...

U.S. CALLS FOR PAUSE ON JOHNSON & JOHNSON VACCINE AFTER CLOTTING CASES / THE NEW YORK TIMES

U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases The Food and Drug Administration and the Centers for Disease Cont...